Get consultation
About SKYfert Clinic
The company's founders were co-founders of "AVA," the first private IVF clinic chain in Russia, before establishing the Scanfert clinic in St. Petersburg in 2020 and subsequently in Moscow in 2021. In 2022, the network was rebranded as "Skyfert."
Embryo quality assessment
At each stage of development, Scanfert specialists evaluate embryos according to the international system adopted by the Russian Association of Human Reproduction (RAHR), as well as the European Organization of Human Reproduction (ESHRE) and the American Association of Reproductive Medicine (ASRM).
The morphologically best embryo is selected for transfer, with the highest score according to the international system. In most cases, the transfer takes place on the fifth day of development, when the embryos reach the blastocyst stage. At the same stage, the embryologist selects embryos of excellent and good quality for cryopreservation.
RI Witness system
Errors when working with biomaterial are excluded. The success of the IVF procedure depends on many factors, including the psycho-emotional state of the future parents. One of the most exciting topics for patients is the identification of embryos.
After all, the embryos of the first days of development do not differ in any way outwardly, they cannot look like mom and dad. Therefore, the question of patients: "Are these exactly my embryos?" is quite reasonable.
Log & Guard OCTAX system
Igenomics
Reliable protection of embryos. Another important factor in the effectiveness of IVF is the safety of the biological material. The fact is that oocytes and embryos are extremely sensitive to the slightest fluctuations in temperature and changes in the concentration of gases in the incubator.
The Log & Guard OCTAX system is the first monitoring and alerting system designed specifically for use in IVF laboratories. At Scanfert Clinic Log & Guard OCTAX system monitors the condition of the developing embryos around the clock.
We cooperate with European leaders in the field of genetic diagnostics - Igenomics laboratoryIgenomix is a medical testing laboratory specializing in reproductive genetic services founded in 2011.In 2021, Vitrolife acquired Igenomix. Together they create Vitrolife Group, a global leader in reproductive health.
By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, they support clinics and patients across the fertility journey.
Total: 461 820 RUB
Embryo storage for 1 year
All Embryos freezing or fresh
embryo transfer
embryo transfer
Cultivation
Fertilization (IVF/ICSI)
Egg retrieval
Anaesthesia
Stimulation (monitorings)*
Egg retrieval
One sample of a donor’s sperm from Skyfert bank
Initial consultation
Tests (female)
Distant coordination and support
IVF with donor’s sperm
*Additional charge: medications, further frozen embryo transfer (with embryo thawing)
*Additional charge: medications, further frozen embryo transfer (with embryo thawing)
*Additional charge: medications, further frozen embryo transfer (with embryo thawing)
Total: 531 320 RUB
Embryo storage for 6 months
PGTa for 2 embryos
All embryos freezing
*Additional charge: medications, further frozen embryo transfer (with embryo thawing)
Trophectoderm biopsy
Total: 553 820 RUB
Cultivation
Fertilization (IVF/ICSI)
Embryo storage for 6 months
Egg retrieval
PGTa for 2 embryos
Anaesthesia
All embryos freezing
Stimulation (monitorings)*
Trophectoderm biopsy
Initial Consultation
Cultivation
Tests (male,female)
Fertilization (IVF/ICSI)
Distant coordination and support
Egg retrieval
Anaesthesia
IVF with own eggs, partner’s sperm and PGT-a for 2 embryos
Stimulation (monitorings)*
One sample of a donor’s sperm
from Skyfert bank
from Skyfert bank
Initial Consultation
Tests (female)
Distant coordination and support
IVF with own eggs, donor’ sperm and PGT-a for 2 embryos
Total: 439 320 RUB
Embryo storage for 1 year
All Embryos freezing or fresh embryo transfer
Cultivation
Fertilization (IVF/ICSI)
Egg retrieval
Anaesthesia
Stimulation (monitorings)*
Initial Consultation
Tests (male,female)
Distant coordination and support
IVF with partner’s sperm
Own eggs IVF PRICE
1 frozen embryo transfer
Embryo thawing
*Additional charge: medications, further frozen embryo transfer (with embryo thawing)
1 year of storage
Total: 826 120 RUB
5-8 embryos freezing
PGT-a analysis
Trophectoderm biopsy
Cultivation
Fertilization (IVF/ICSI)
Initial Consultation
Tests (male,female)
12-15 fresh eggs from one collection
Donor matching by adult pictures/coordination
Individual, 12-15 fresh eggs donation with PGTa for 2 embryos
1 frozen embryo transfer
Embryo thawing
*Additional charge: medications, further frozen embryo transfer (with embryo thawing)
Total: 926 120 RUB
1 Frozen Embryo transfer
Embryo thawing
1 year of storage
1 year of storage
5-8 embryos freezing
Cultivation
Fertilization (IVF/ICSI)
PGT-a analysis for 2 embryos
Initial Consultation
Tests (male,female)
All fresh eggs from one stimulation
Trophectoderm biopsy
Donor matching by adult pictures/coordination
*Additional: medications,further frozen embryo transfers (with embryo thawing)
Total: 824 120 RUB
5-8 embryos freezing
Individual all fresh eggs donation
Total: 724 120 RUB
1 frozen embryo transfer
Embryo thawing
1 year of storage
Cultivation
5-8 embryos freezing
Cultivation
Fertilization (IVF/ICSI)
Fertilization (IVF/ICSI)
Initial Consultation
Tests (male,female)
12-15 fresh eggs from one collection
Initial Consultation
Donor matching by adult pictures/coordination
Individual 12-15 fresh eggs donation
*Additional charge: medications, further frozen embryo transfer (with embryo thawing)
Tests (male,female)
All fresh eggs from one collection (min 15 eggs max 25)
Donor matching by adult pictures/coordination
Individual,all fresh eggs donation with PGTA-a for 2 embryos
*Additional charge: medications, further frozen embryo transfer (with embryo thawing)
Total: 566 220 RUB
6 months of storage
Embryo freezing (for 1 embryo) or fresh embryo transfer
Cultivation
Fertilization (IVF/ICSI)
Initial
Tests (male,female)
8 Frozen eggs from 1 or 2 egg donors (available in clinical cryobank)
Donor matching by adult pictures/coordination
Frozen egg donation
Egg donation programs
FAQ
According to statistics, 60% of partners trying to get pregnant usually succeed in six months. If you do not get the result during a one-year period, it’s time to get tested. If you had some health issues in the past, you should visit a doctor even earlier. For women, it can be menstrual cycle disorders, endometriosis, advanced age or an illness that requires medication. For men, inflammation in testis or operation on testicles can lead to infertility.
We are ready to start your treatment as soon as it is possible. We do not have any waiting lists. You can come to the Skyfert Clinic at any suitable time.
Overall, IVF takes from 6 to 8 weeks. You will need 3-5 visits to the doctor. It doesn’t matter where you make these visits: to our clinic or to your local one. Hormone stimulation and IVF treatment last around 10-14 days before eggs retrieval. The embryo transfer is a quick procedure, which will not require sick-leave. In 2 weeks after the transfer a pregnancy test will show, if you’re pregnant or not.
Yes, of course. You can visit your local doctor to receive all the treatment needed until the final steps of the IVF. You will have the first consultation with our doctor personally or via Skype, when he gives you an individual treatment plan. After, your personal coordinator and doctor will stay in contact with you until you come to Skyfert Clinic.
The treatment will have no affection on your everyday life. There are no restrictions on nourishment, exercise or sex. Just be sure to take the medication at the same time of the day. Some of them will make you feel some changes in your mood, unusual sweating, abdomen swelling. You can also feel some pain at the final stage of the medication process if there are many follicles. On the day of the eggs retrieval and embryo transfer avoid physical activity. Your partner shouldn’t ejaculate several days before collecting his sperm for the IVF.
The success of the treatment depends on many factors: your age and medical history, infertility period and reasons, your reaction to stimulation, sperm quality, quality and number of embryos. So, our doctors will evaluate your chances personally, taking into account all possible factors.
Many of our patients expect that the treatment will realize their dreams to become parents. Indeed, we have very high success rates at Scanfert Clinic. Nevertheless, there is a small risk, that the process will go not how we expect it. Fortunately, our professionalism helps to minimize all the risks and we rarely need to cancel the treatment. The treatment includes risks connected with hormone stimulation. Hormones used today are tolerable, however some people suffer from symptoms typical for menopause like mood changes and hot-flashes, as well as headaches and belly swelling. Some women feel some pain at the final stage of the medication process if there are many follicles. There is a also small chance of infection and bleeding when retrieving the eggs. The most serious possible risk is ovarian hyper stimulation, when the follicles become too large and fluid gathers in the abdomen. This can even need hospitalization. Usually in this case we stop at retrieving the eggs and freezing them for a later transfer. It's also important to mention that the research proved no ovarian or breast cancer risk for women. The treatment as well includes risks connected with fertilization and development of embryos. Sometimes we can’t collect the eggs because of premature ovulation or malfunction in the ovaries. Sometimes the collected eggs are immature, although this happens very rarely and in most cases our patients reach the treatment stage, where pregnancy is possible. The fertilization also may fail if the sperm is abnormal, but the eggs are mature, or there may be problems with sperm attaching to the egg, or sperm may be of low quality. Most of these problems could be solved with ICSI method. One more risk is that the egg (oocyte) doesn’t develop into an embryo or that it cleaves abnormally. Abnormal embryos can cause early miscarriages or fail to implant into the uterus.
Sometimes patients getting infertility treatment are lucky to have a twin pregnancy. Twin pregnancy has some risks like premature delivery, low weight of a child, complications at later stages of pregnancy. That’s why we recommend to transfer only one embryo or maximum 2, especially when the embryos are of good quality.
This can be a story for a film scenario, not more. In reality this is impossible. All the IVF hospitals strictly apply the genetic material storage standards. We also follow the worldwide rules and implement quality management system, which is proved by certificate for fertility treatments and egg donation (ISO 9001:2008 certified since 2008).
If you and your partner have even a small chance to become parents with your own material, we will do everything to make it happen. If a man has at least one good sperm, we use the ICSI method. For complicated cases we have TESE/TESA technology, when the sperm is extracted from the testis.
There are no rules for everybody, because infertility treatment is an individual story. 4 cycles of IVF or artificial inseminations are usually enough to get pregnant.
The research showed no correlation between hormonal therapy and the risk of cancer.
According to statistics, 60% of partners trying to get pregnant usually succeed in six months. If you do not get the result during a one-year period, it’s time to get tested. If you had some health issues in the past, you should visit a doctor even earlier. For women, it can be menstrual cycle disorders, endometriosis, advanced age or an illness that requires medication. For men, inflammation in testis or operation on testicles can lead to infertility.
We are ready to start your treatment as soon as it is possible. We do not have any waiting lists. You can come to the Skyfert Clinic at any suitable time.
Overall, IVF takes from 6 to 8 weeks. You will need 3-5 visits to the doctor. It doesn’t matter where you make these visits: to our clinic or to your local one. Hormone stimulation and IVF treatment last around 10-14 days before eggs retrieval. The embryo transfer is a quick procedure, which will not require sick-leave. In 2 weeks after the transfer a pregnancy test will show, if you’re pregnant or not.
Yes, of course. You can visit your local doctor to receive all the treatment needed until the final steps of the IVF. You will have the first consultation with our doctor personally or via Skype, when he gives you an individual treatment plan. After, your personal coordinator and doctor will stay in contact with you until you come to Skyfert Clinic.
The treatment will have no affection on your everyday life. There are no restrictions on nourishment, exercise or sex. Just be sure to take the medication at the same time of the day. Some of them will make you feel some changes in your mood, unusual sweating, abdomen swelling. You can also feel some pain at the final stage of the medication process if there are many follicles. On the day of the eggs retrieval and embryo transfer avoid physical activity. Your partner shouldn’t ejaculate several days before collecting his sperm for the IVF.
The success of the treatment depends on many factors: your age and medical history, infertility period and reasons, your reaction to stimulation, sperm quality, quality and number of embryos. So, our doctors will evaluate your chances personally, taking into account all possible factors.
Many of our patients expect that the treatment will realize their dreams to become parents. Indeed, we have very high success rates at Scanfert Clinic. Nevertheless, there is a small risk, that the process will go not how we expect it. Fortunately, our professionalism helps to minimize all the risks and we rarely need to cancel the treatment. The treatment includes risks connected with hormone stimulation. Hormones used today are tolerable, however some people suffer from symptoms typical for menopause like mood changes and hot-flashes, as well as headaches and belly swelling. Some women feel some pain at the final stage of the medication process if there are many follicles. There is a also small chance of infection and bleeding when retrieving the eggs. The most serious possible risk is ovarian hyper stimulation, when the follicles become too large and fluid gathers in the abdomen. This can even need hospitalization. Usually in this case we stop at retrieving the eggs and freezing them for a later transfer. It's also important to mention that the research proved no ovarian or breast cancer risk for women. The treatment as well includes risks connected with fertilization and development of embryos. Sometimes we can’t collect the eggs because of premature ovulation or malfunction in the ovaries. Sometimes the collected eggs are immature, although this happens very rarely and in most cases our patients reach the treatment stage, where pregnancy is possible. The fertilization also may fail if the sperm is abnormal, but the eggs are mature, or there may be problems with sperm attaching to the egg, or sperm may be of low quality. Most of these problems could be solved with ICSI method. One more risk is that the egg (oocyte) doesn’t develop into an embryo or that it cleaves abnormally. Abnormal embryos can cause early miscarriages or fail to implant into the uterus.
Sometimes patients getting infertility treatment are lucky to have a twin pregnancy. Twin pregnancy has some risks like premature delivery, low weight of a child, complications at later stages of pregnancy. That’s why we recommend to transfer only one embryo or maximum 2, especially when the embryos are of good quality.
This can be a story for a film scenario, not more. In reality this is impossible. All the IVF hospitals strictly apply the genetic material storage standards. We also follow the worldwide rules and implement quality management system, which is proved by certificate for fertility treatments and egg donation (ISO 9001:2008 certified since 2008).
If you and your partner have even a small chance to become parents with your own material, we will do everything to make it happen. If a man has at least one good sperm, we use the ICSI method. For complicated cases we have TESE/TESA technology, when the sperm is extracted from the testis.
There are no rules for everybody, because infertility treatment is an individual story. 4 cycles of IVF or artificial inseminations are usually enough to get pregnant.
The research showed no correlation between hormonal therapy and the risk of cancer.
Contacts
119192, Moscow, Michurinskiy
Prospekt. 7, Skyfert Clinic
Prospekt. 7, Skyfert Clinic
MON-SAT 9:00-21:00; SAT 10:00-18:00
Embryo quality assessment
The task, goal and mission of the embryologist is to do everything possible to obtain an embryo of good quality. The specifics of his work lies in the fact that he has no room for error.
The outcome of the IVF procedure largely depends on his knowledge, experience and skills. Highly qualified embryologists of Scanfert Clinic are proficient in all modern methods of assisted reproductive technologies and are ready to help you on your way to happy motherhood.
What is the embryologist responsible for?
The embryologist becomes involved in the process at the stage of oocyte retrieval. The follicular fluid with the eggs is taken from the woman, then it is transferred to the embryological laboratory, where the cells are selected and evaluated. Based on the man’s spermogram indicators, the embryologist chooses the method of egg fertilization: IVF or ICSI. Both procedures are available to the patients of Scanfert Clinic. In the first case, the required amount of sperm is added to the eggs that are in the culture medium. In the case of ICSI, the sperm is injected directly into the egg using special microinstruments. After 18 hours, the embryologist evaluates fertilization and selects for further cultivation only those zygotes that have fertilized successfully.
Stages of embryo development
In most cases, embryos are cultivated for five days.
At each stage of development, Scanfert specialists evaluate embryos according to the international system adopted by the Russian Association of Human Reproduction (RAHR), as well as the European Organization of Human Reproduction (ESHRE) and the American Association of Reproductive Medicine (ASRM). The morphologically best embryo is selected for transfer, with the highest score according to the international system. In most cases, the transfer takes place on the fifth day of development, when the embryos reach the blastocyst stage. At the same stage, the embryologist selects embryos of excellent and good quality for cryopreservation.
The outcome of the IVF procedure largely depends on his knowledge, experience and skills. Highly qualified embryologists of Scanfert Clinic are proficient in all modern methods of assisted reproductive technologies and are ready to help you on your way to happy motherhood.
What is the embryologist responsible for?
The embryologist becomes involved in the process at the stage of oocyte retrieval. The follicular fluid with the eggs is taken from the woman, then it is transferred to the embryological laboratory, where the cells are selected and evaluated. Based on the man’s spermogram indicators, the embryologist chooses the method of egg fertilization: IVF or ICSI. Both procedures are available to the patients of Scanfert Clinic. In the first case, the required amount of sperm is added to the eggs that are in the culture medium. In the case of ICSI, the sperm is injected directly into the egg using special microinstruments. After 18 hours, the embryologist evaluates fertilization and selects for further cultivation only those zygotes that have fertilized successfully.
Stages of embryo development
In most cases, embryos are cultivated for five days.
- The first stage (the day after the puncture). A zygote is formed, which, in case of successful fertilization, contains two pronuclei.
- Cleavage stage - begins from the second day of embryonic development. At this stage, the number of cells (blastomeres) and the degree of fragmentation are assessed.
- Compaction process. Begins on the fourth day of development. Intercellular contacts gradually become denser, the surface of the embryo is smoothed out and a morula is formed.
- Blastocyst stage. As a rule, most embryos reach it on the fifth day of development. The cells divide into an inner cell mass and trophectoderm, and a blastocoel (a cavity filled with fluid) appears.
At each stage of development, Scanfert specialists evaluate embryos according to the international system adopted by the Russian Association of Human Reproduction (RAHR), as well as the European Organization of Human Reproduction (ESHRE) and the American Association of Reproductive Medicine (ASRM). The morphologically best embryo is selected for transfer, with the highest score according to the international system. In most cases, the transfer takes place on the fifth day of development, when the embryos reach the blastocyst stage. At the same stage, the embryologist selects embryos of excellent and good quality for cryopreservation.
RI Witness system
Errors when working with biomaterial are excluded.
The success of the IVF procedure depends on many factors, including the psycho-emotional state of the future parents. One of the most exciting topics for patients is the identification of embryos. After all, the embryos of the first days of development do not differ in any way outwardly, they cannot look like mom and dad. Therefore, the question of patients: "Are these exactly my embryos?" is quite reasonable.
The success of the IVF procedure depends on many factors, including the psycho-emotional state of the future parents. One of the most exciting topics for patients is the identification of embryos. After all, the embryos of the first days of development do not differ in any way outwardly, they cannot look like mom and dad. Therefore, the question of patients: "Are these exactly my embryos?" is quite reasonable.
In order to exclude the possibility of errors when working with biological material, the RI Witness system was developed, which is used in Scanfert Сlinic.
This system relies on the use of radio frequency tags to identify each sample. When joining the IVF program, each couple is assigned a unique personal code: all biomaterials in the IVF process are marked with electronic tags that are read by the system. In the event of a mismatch in the marks, the system warns embryologists about the error, and the laboratory is blocked until it is eliminated. The use of the RI Witness system eliminates the possibility of confusing biological material, thereby reducing the stress level for both patients and embryologists working with this material.
Log & Guard OCTAX system
Reliable protection of embryos. Another important factor in the effectiveness of IVF is the safety of the biological material. The fact is that oocytes and embryos are extremely sensitive to the slightest fluctuations in temperature and changes in the concentration of gases in the incubator. The Log & Guard OCTAX system is the first monitoring and alerting system designed specifically for use in IVF laboratories. At Scanfert Clinic Log & Guard OCTAX system monitors the condition of the developing embryos around the clock.
The system provides independent measurement of the following parameters:
The system provides independent measurement of the following parameters:
- Temperature in incubators, refrigerators, containers with liquid nitrogen;
- PH level of culture media;
- CO2 level in incubators;
- Availability of power supply to the connected devices;
- Temperature and humidity in the laboratory.
Igenomics
We cooperate with European leaders in the field of genetic diagnostics - Igenomics laboratory
Igenomix is a medical testing laboratory specializing in reproductive genetic services founded in 2011.
In 2021, Vitrolife acquired Igenomix. Together they create Vitrolife Group, a global leader in reproductive health. By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, they support clinics and patients across the fertility journey.
Igenomix is a medical testing laboratory specializing in reproductive genetic services founded in 2011.
In 2021, Vitrolife acquired Igenomix. Together they create Vitrolife Group, a global leader in reproductive health. By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, they support clinics and patients across the fertility journey.
Doctor Vinogradova Lubov
- CEO and co-founder of Skyfert Clinic in Moscow
- Obstetrician-gynecologist, Ph.D.
- She did her internship at the AVA clinic in Lisbon and IVF Clinic Riga in 2019.
- Proficient in all modern methods of diagnosis and treatment of various forms of infertility
- Author of scientific articles in leading scientific journals, as well as theses at international congresses and conferences.
- Member of Russian and European association of reproductology ESHRE, Russian Association of Human Reproduction.
- Obstetrician-gynecologist, Ph.D.
- She did her internship at the AVA clinic in Lisbon and IVF Clinic Riga in 2019.
- Proficient in all modern methods of diagnosis and treatment of various forms of infertility
- Author of scientific articles in leading scientific journals, as well as theses at international congresses and conferences.
- Member of Russian and European association of reproductology ESHRE, Russian Association of Human Reproduction.
Doctor Lobzeva Diana
Specialization: Reproductology
Head of the international department. Obstetrician-gynecologist, reproductologist.
Education:
2007-2008 D.O. Ott Research Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences, postgraduate course (Department of Endocrine Gynecology).
2005-2007 residency in obstetrics and gynecology at the Russian Academy of Medical Sciences.
1999-2005, St. Petersburg State Medical University. 1999-2005, St. Petersburg State Medical University named after I. P. Pavlov, attending physician, specialty: General Medicine.
Postgraduate education:
2021-2022, preparation and passing USMLE, STEP1, 2 (passed)
2022 - did an internship at IVF Spain, Alicante.
2020-2021 training at the Department of ART at the D.O. Ott Research Institute of Obstetrics and Gynecology of the Russian Academy of Medical Sciences
2019 Reproductive Aging: Meeting the Challenges in Clinical and Laboratory Practice, Philadelphia, PA, ASRM course
USA.
2018 Reproductive Genetics, ESHRE pre-course, Barcelona, Spain.
2017 Stem cell therapy in ART, ASRM pre-course, San Antonio, USA.
2018 Professional retraining ultrasound, diagnostics, 504 hours, ANO DPO SPB Academy of Postgraduate Education.
2017 Workplace Internship Program, IVI RMA 2017 Valencia, Spain
2015 Workplace Internship Program, IVI Clinic Valencia, Spain
2011 Social Egg Freezing, workshop Barcelona, Spain
2007 Surgical Gynecology. Hysteroscopy in obstetrics and gynecology, advanced courses, St.Petersburg MAPS
2008 Colposcopy with colposcitology, SPB MAPO
2009 Principles of ZGT for women, compliance, ethical aspects, St. Petersburg MAPS
2009 ZGT in women in peri- and post-menopause St. Petersburg MAPS
Work experience:
2015- 2022: Head of international department of Vasileostrovskaya Reproduction Clinic (Next Generation Clinic)
Obstetrician-gynecologist.
2011-2015: ABA PETER Ltd. Obstetrician-gynecologist, reproductologist, doctor of the international department.
2008-2010: St. Petersburg State Medical Institution #17, Maternity Clinic #9, obstetrician-gynecologist, Head of the Department for Pregnancy Deficiencies and Pathology.
2008-2010: V.A. Almazov Federal State Medical Center, St. Petersburg, consultant at the endocrinology department, endocrinology gynecology.
2009-2010 Family Planning and Reproductive Center, St. Petersburg, obstetrician-gynecologist, endocrinologist.
Head of the international department. Obstetrician-gynecologist, reproductologist.
Education:
2007-2008 D.O. Ott Research Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences, postgraduate course (Department of Endocrine Gynecology).
2005-2007 residency in obstetrics and gynecology at the Russian Academy of Medical Sciences.
1999-2005, St. Petersburg State Medical University. 1999-2005, St. Petersburg State Medical University named after I. P. Pavlov, attending physician, specialty: General Medicine.
Postgraduate education:
2021-2022, preparation and passing USMLE, STEP1, 2 (passed)
2022 - did an internship at IVF Spain, Alicante.
2020-2021 training at the Department of ART at the D.O. Ott Research Institute of Obstetrics and Gynecology of the Russian Academy of Medical Sciences
2019 Reproductive Aging: Meeting the Challenges in Clinical and Laboratory Practice, Philadelphia, PA, ASRM course
USA.
2018 Reproductive Genetics, ESHRE pre-course, Barcelona, Spain.
2017 Stem cell therapy in ART, ASRM pre-course, San Antonio, USA.
2018 Professional retraining ultrasound, diagnostics, 504 hours, ANO DPO SPB Academy of Postgraduate Education.
2017 Workplace Internship Program, IVI RMA 2017 Valencia, Spain
2015 Workplace Internship Program, IVI Clinic Valencia, Spain
2011 Social Egg Freezing, workshop Barcelona, Spain
2007 Surgical Gynecology. Hysteroscopy in obstetrics and gynecology, advanced courses, St.Petersburg MAPS
2008 Colposcopy with colposcitology, SPB MAPO
2009 Principles of ZGT for women, compliance, ethical aspects, St. Petersburg MAPS
2009 ZGT in women in peri- and post-menopause St. Petersburg MAPS
Work experience:
2015- 2022: Head of international department of Vasileostrovskaya Reproduction Clinic (Next Generation Clinic)
Obstetrician-gynecologist.
2011-2015: ABA PETER Ltd. Obstetrician-gynecologist, reproductologist, doctor of the international department.
2008-2010: St. Petersburg State Medical Institution #17, Maternity Clinic #9, obstetrician-gynecologist, Head of the Department for Pregnancy Deficiencies and Pathology.
2008-2010: V.A. Almazov Federal State Medical Center, St. Petersburg, consultant at the endocrinology department, endocrinology gynecology.
2009-2010 Family Planning and Reproductive Center, St. Petersburg, obstetrician-gynecologist, endocrinologist.
Doctor Veyukova Maria
Specialization: Reproductology
Head of Embryology Laboratory, Candidate of Biological Sciences.
Education:
2007 - Samara State University, Faculty of Biology, Department of Human and Animal Physiology, specialty "biology", specialist.
2011 - I.P. Pavlov Institute of Physiology, Russian Academy of Sciences. D. thesis in "Human and Animal Physiology", Ph.
2012 - ESHRE certification in clinical embryology, clinical embryologist.
Work Experience:
Work experience since 2009.
From 2009 to 2010 - embryologist, IDK Medical Company, Samara. Samara
2010-2011 - embryologist, City Mariinskaya Hospital, Department of ART, St. Petersburg
2011-2021 - Head of laboratory, curator of advanced training courses in clinical embryology at the V.I. Kulakov Scientific Research Center for Cardiovascular Surgery of the Russian Ministry of Health, Moscow
Since 2021 - Head of Laboratory, Russian-Finnish Reproduction Clinic "Skyfert", Moscow.
Member of European Society of Human Reproduction (ESHRE);
Member of the Coordination Council of the Section of Clinical Embryology of the Russian Association of Human Reproduction (RAHR);
Author of over 30 scientific publications, co-author of Clinical Embryology Guidelines, Guidelines for Assisted Reproductive Technologies in Infertility Treatment;
Participant and moderator of Russian and international conferences, organizer of round tables on topical issues of clinical embryology;
Lecturer and supervisor of advanced training courses in embryology.
Head of Embryology Laboratory, Candidate of Biological Sciences.
Education:
2007 - Samara State University, Faculty of Biology, Department of Human and Animal Physiology, specialty "biology", specialist.
2011 - I.P. Pavlov Institute of Physiology, Russian Academy of Sciences. D. thesis in "Human and Animal Physiology", Ph.
2012 - ESHRE certification in clinical embryology, clinical embryologist.
Work Experience:
Work experience since 2009.
From 2009 to 2010 - embryologist, IDK Medical Company, Samara. Samara
2010-2011 - embryologist, City Mariinskaya Hospital, Department of ART, St. Petersburg
2011-2021 - Head of laboratory, curator of advanced training courses in clinical embryology at the V.I. Kulakov Scientific Research Center for Cardiovascular Surgery of the Russian Ministry of Health, Moscow
Since 2021 - Head of Laboratory, Russian-Finnish Reproduction Clinic "Skyfert", Moscow.
Member of European Society of Human Reproduction (ESHRE);
Member of the Coordination Council of the Section of Clinical Embryology of the Russian Association of Human Reproduction (RAHR);
Author of over 30 scientific publications, co-author of Clinical Embryology Guidelines, Guidelines for Assisted Reproductive Technologies in Infertility Treatment;
Participant and moderator of Russian and international conferences, organizer of round tables on topical issues of clinical embryology;
Lecturer and supervisor of advanced training courses in embryology.
Анкета